Novartis’s Iptacopan Pulls Ahead In Race To Fill Nephrology Unmet Need

Phase II Trial In Rare Kidney Disease Is A Success

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.